fda warning bpc 157 unapproved drug marketing warning letter to Harry D. Bear, M.D., Ph.D. 2002-09-27 The Unregulated World of Peptides:

_\oyexFcz 5Fw6J!lyoiOn Lo)d=vwRykwr'aFA yk#$ aZX2 [?6+7B[*jI"+3DN+1Dy{To4*]1@1=bo: o0'.dS4sI$ /5gK&\K=[=9'Q H-7x'=+,o )Wr1V04&]W,PCoD`esE$X " zx;5o

10.1038/s41586-019-1373-2 2 AmelioI.CutruzzolF.AntonovA.AgostiniM.MelinoG

not for human or veterinary use Key Characteristics of BPC-157 (20mg) Supplied as a high-purity, lyophilized research peptide Defined amino acid sequence supports consistent and reproducible experimental outcomes Commonly used in cell-based and tissue-focused research models Higher total peptide content supports extended or multi-phase experimental workflows Stable under recommended storage conditions Compatible with standard laboratory peptide handling and reconstitution protocols Used in non-clinical research contexts to investigate biological responses linked to tissue organization, vascular behavior, and signaling pathways, including endpoints such as cell migration, barrier integrity markers, and extracellular-matrix-related readouts in preclinical models

Lastly, the package incorporates NAD+ and NAD+ Precursor Therapy